Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is launching Capsugel Colorista, a high-quality capsule based on an “all-colorants” formulation. The new capsule further expands the Lonza Capsugel R&D offering. 

Colorista capsules contain a broad selection of colorants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colors, and are available in both Vcaps Plus (HPMC) and Coni-Snap gelatin.

“A common issue faced by drug product developers is that the color composition choice for the commercial drug product is often made after initial stability studies,” said Emmanuelle Saugues, Color Lab EMEA supervisor for Lonza. “If new colors are introduced, it may require additional studies, which can result in costly delays. To address this problem, we have developed Colorista capsules at the Capsugel Color Lab.”  

Colorista capsules offer more than 150 color options in Coni-Snap gelatin capsules and more than 50 color options in Vcaps Plus capsules and are available in different sizes to enable the encapsulation of a wide range of doses and formulations.

“Colorista capsules meet the demand of our pharmaceutical customers who look for solutions that cut down on development time while giving them flexibility to progress with technical development before the final commercial color decision is taken,” Niki Kolokotronis, sales director Americas for Capsule Delivery Solutions, said. 

(Source: Lonza Group Ltd.)